Cre-Expressing Human Primary Aortic Fibroblasts
Quick Actions
Documentation 0 files
Product Overview
Description
Cre-expressing Human Primary Aortic Fibroblasts are specialized cells derived from human aortic tissue that have been genetically modified to express the Cre recombinase enzyme. This allows for targeted genetic modifications in studies involving gene knockout or transgenesis when crossed with suitable reporter or loxP-flanked genetic constructs.
IMPORTANT: Quality warranty requires use of NeoBioPharma media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.
Key Features
Catalog Number: NBP-1781Cre
Product Format: Frozen
Vial Cell Number: > 5x10[5] cells/vial
Passage:1(P1)
Storage: Liquid Nitrogen, Vapor Phase
Intended Use: Research use only (RUO)
Characterization
- Verify expression of Cre by PCR or Western blotting.
- Assess cellular morphology and growth characteristics using microscopy.
- Confirm the absence of contamination by monitoring growth rates and cellular behavior.
Quick Facts
Product Type
Endothelial Cells (Cre-expressing)
Viability
>95% viable (Trypan Blue exclusion)
Applications
Research & Development
Availability
In Stock • Global Shipping
Technical Specifications
Applications & Use Cases
Research Areas
In Vitro Studies
Cell culture and screening applications
Molecular Biology
Gene expression & signaling studies
Drug Discovery
Screening & validation studies
Disease Modeling
Pathophysiology research
Support & Resources
Technical Support
Our experts are available for technical questions and protocol assistance.
Contact Support
